Orchestra BioMed Holdings (OBIO) Inventory Average (2023 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Inventory Average came in at $293500.0 in Q1 2026, up 90.58% year-on-year from $154000.0 in Q1 2025, and down 13.04% on a QoQ basis from $337500.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Inventory Average (2023 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 4 years of Inventory Average data on file, last reported at $293500.0 in Q1 2026.
- On a quarterly basis, Inventory Average rose 90.58% year-over-year to $293500.0 in Q1 2026; TTM through Mar 2026 was $293500.0, a 90.58% increase from a year earlier, with the FY2025 full-year figure at $241500.0, up 51.41% from the prior year.
- Inventory Average for Q1 2026 stood at $293500.0, down from $337500.0 in the prior quarter.
- Over the last five years, Inventory Average for OBIO reached as high as $337500.0 in Q4 2025 and fell as low as $92500.0 in Q2 2024.
- Historically, Inventory Average has averaged $196653.8 across 4 years, with a median of $160000.0 in 2025.
- Across the five-year window, Inventory Average slumped 54.88% in 2024 and soared 90.58% in 2026, its largest moves.
- Year by year, Inventory Average stood at $141500.0 in 2023, then surged by 43.82% to $203500.0 in 2024, then soared by 65.85% to $337500.0 in 2025, then retreated by 13.04% to $293500.0 in 2026.
- Per Business Quant data, the three most recent Inventory Average figures were $293500.0 in Q1 2026, $337500.0 in Q4 2025, and $275000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Orchestra BioMed Holdings | 235.83 Mn | 141.43 Mn | 78,000.00 | 293,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 293,500.00 |
| Dec 31, 2025 | 337,500.00 |
| Sep 30, 2025 | 275,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 154,000.00 |
| Dec 31, 2024 | 203,500.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 92,500.00 |
| Mar 31, 2024 | 130,500.00 |
| Dec 31, 2023 | 141,500.00 |
| Sep 30, 2023 | 157,500.00 |
| Jun 30, 2023 | 205,000.00 |
| Mar 31, 2023 | 254,000.00 |